Drug · DIN 02489627
IDELVION
KIT CONTAINING: A) VIAL (IDELVION POWDER) AND B) DILUENT (5 ML STERILE WATER, VIAL)
Authorized, not yet reported as sold
Authorized for sale in Canada; the company has not yet told Health Canada that it is on the market.
Status Approved since June 18, 2019.
- Drug Identification Number (DIN)
- 02489627
- Company (DIN owner)
- Csl Behring Canada IncOttawa, Ontario, Canada
- Schedule
- Schedule D
- Dosage form
- Kit; Powder For Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- Coagulation factor ix B02BD04
- Class
- Human
- Record last updated
- September 21, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| COAGULATION FACTOR IX (RECOMBINANT), ALBUMIN FUSION PROTEIN (RIX-FP) | 3500 UNIT | VIAL |
Notices of Compliance
Health Canada approvals that name this DIN.
- June 18, 2019: NOC 22302Supplement to a New Drug Submission (SNDS) · New strength
Other DINs named IDELVION
- DIN 02451336 · Approved
- DIN 02451344 · Approved
- DIN 02451352 · Dormant
- DIN 02451360 · Approved